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DNA methylationCurrent standard practices for treatment of cancers are less than satisfactory because of recurrence
mediated by cancer stem cells (CSCs). Caffeic acid (CaA) is a novel anti-tumor agent that inhibits pro-
liferation, migration, and invasion in human cancer cells. However, little is known about the func-
tions of CaA in regulating CSCs-like properties and the potential molecular mechanisms. Here, we
found that CaA attenuated the CSCs-like properties by the microRNA-148a (miR-148a)-mediated
inhibition of transforming growth factor beta (TGFb)-SMAD2 signaling pathway both in vitro and
in vivo. CaA enhanced the expression of miR-148a by inducing DNA methylation. MiR-148a, which
targeted the SMAD2-30UTR, decreased the expression of SMAD2. Knockdown of miR-148a abolished
the CaA-induced inhibition of TGFb-SMAD2 signal pathway and the CSCs-like properties. Our study
found a novel mechanism that CaA inhibits the CSCs-like properties via miR-148a-mediated inhibi-
tion of TGFb-SMAD2 signaling pathway, which may help to identify a new approach for the treat-
ment of human cancers.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction metabolism and interactions with the microenvironment [5,6].The cancer stem cells (CSCs) hypothesis states that the charac-
teristic of neoplastic tissues is the existence of self-renewing,
stem-like cells, which constitute a small portion of the neoplastic
cells and exhibit the capacity to produce new tumors [1]. There
is mounting evidence that CSCs occur in human solid tumors,
including those found in breast, liver, colon and lung [1–3]. The
elevation of CSCs-like properties is involved in the initiation,
tumorigenesis, metastasis, angiogenesis, and recurrence of various
human cancers [1,4]. The efﬁcacy of standard chemotherapy treat-
ments for cancer are decreased by the properties of CSCs, which
include self-renewal, lack of differentiation, quiescence, distinct
epigenetic state, deregulation of apoptotic/survival pathways,For example, the cytotoxic chemotherapies such as taxanes and
cisplatin are less than satisfactory partly because of the
toxic/side-effects and induction the generation of CSCs [5,7]. So
the continued search for novel naturally agents, which exhibit less
cytotoxic and have repressive effects on CSCs or the cancer cells
with CSCs-like properties are urgently needed.
Caffeic acid (3,4-dihydroxycinnamic acid, CaA), a naturally
occurring hydroxycinnamic acid derivatives, is an active component
in the phenolic propolis extract and also in a wide variety of plants
[8]. Caffeic acid has several biological and pharmacological proper-
ties, such as antiviral, antioxidants, anti-inﬂammatory, and
immunomodulatory activates [9]. In addition to these functions,
CaA exerts anticancer effects. CaA decreases the viability of human
hepatocellular carcinoma (HCC) HepG2 and Huh-7 cells in a
time-dependent manner [10]. Meanwhile, it inhibits the DNA
methylation in human breast cancer (BC) MCF-7 and
MDA-MB-231 cells [11]. Moreover, CaA has been identiﬁed as a
new matrix metalloproteinase-9 inhibitor, which may be involved
in tumor cell invasion and metastasis [12]. Further, CaA and its
derivative, caffeic acid phenethyl ester (CAPE), suppress the angio-
genesis of human renal carcinoma cells by blocking
Table 1
Primers used for qRT-PCR.
Genes Primers (50–30)
CD44 TGAGCATCGGATTTGAGAC (F)
CATACTGGGAGGTGTTGGA (R)
EpCAM AAGGAGAAACAGGAAACCTC (F)
ACAGACACAGTCCAACTTCC (R)
ALDH-1 TGTCCAAGTCGGCATCAG (F)
GGCAGCCATTTCTTCTCA (R)
4-Oct GCTTCCTCCACCCACTTCT (F)
GTATTCAGCCAAACGACCAT (R)
BMI-1 CTGATGACCCATTTACTGA (F)
CTCCACCTCTTCTTGTTTG (R)
SMAD2 GTTCCTGCCTTTGCTGAC (F)
TCTCTTTGCCAGGAATGCTT (R)
Snail TTCTCCCGAATGTCCCT (F)
TCAGCCTTTGTCCTGTAGC (R)
CDH-1 TGCTCACATTTCCCAACTC (F)
TCTGTCACCTTCAGCCATC (R)
Lin-28B CCTTGAGTCAATACGGGT (F)
ACGGTAATGACAGTCTCG (R)
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demonstrated that, in breast CSCs isolated fromMDA-MB-231 cells,
CAPE causes pronounced changes in breast CSCs characteristics
manifested by inhibition of self-renewal, progenitor formation,
and clonal growth in soft agar [14]. However, the molecular
mechanisms underlying in the CaA-induced repressive effects on
CSCs or the cancer cells with CSCs-like properties remain largely
uninvestigated.
We previously showed that blockage of TGFb/SMADs signal
pathway is involved in the glabridin-induced inhibition of
CSCs-like properties in HCC cells [15]. Here we treated human
triple-negative breast cancer (TNBC) cell line, MDA-MB-231, and
human HCC cell line, MHCC97H, by CaA in vitro and in vivo to
investigate the relationships among CaA, TGFb/SMADs signal path-
way, and CSCs-like properties, and to determine the underlying
molecular mechanisms.
2. Materials and methods
2.1. Cell culture and reagents
Human TNBC cell line, MDA-MB-231, was obtained from
American Type Culture Collection (ATCC, Rockville, MD, USA).
Human HCC cell line, MHCC97H, was obtained from the Liver
Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai,
China [16]. MDA-MB-231 cells were maintained at 37 C in the
absence of CO2 in L-15 medium (Life Technologies/Gibco, Grand
Island, NY, USA), while the MHCC97H cells were maintained in
5% CO2 at 37 C in Dulbecco’s Modiﬁed Eagle Medium (DMEM,
Gibco). Both mediums were supplemented with 10% fetal bovine
serum (FBS, Gibco), 100 U/ml penicillin, and 100 mg/ml strepto-
mycin (Gibco). The caffeic acid (CaA, purityP 99%) and
S-adenosylmethionine (SAM, a methyl donor) were purchased
from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Animals
This study was performed according to a protocol approved by
the Nanjing Medical University Institutional Animal Care and Use
Committee (Permit Number: NJMU-IACUC-1403022). Brieﬂy, the
BALB/c nude mice were kept in a temperature controlled environ-
ment (20–22 C) with a 12 h light dark cycle and with free access to
drinking water and chow. For xenograft, 5  106 MHCC97H cells
were injected subcutaneously into the right armpit of the mice.
After the establishment of the tumors, CaA (0 or 10 mg/kgBW)
was administered intraperitoneally [i.p [13]] twice per week.
Tumor volumes were measured weekly and tumor size was calcu-
lated using the formula: V = ½ (width2  length) [8]. After
11 weeks, mice were sacriﬁced, and the tumor tissues were
removed for further investigation.
2.3. Quantitative real-time polymerase chain reaction (qRT-PCR)
Primers used were listed in Table 1. The miRNA primers were
synthesized by RiboBio Co. (Guangzhou, China). Total RNA was iso-
lated using Trizol (Invitrogen, Carlsbad, USA) according to the man-
ufacturer’s recommendations. For detection of mRNAs, total RNA
(2 lg) was transcribed into cDNA using AMV Reverse
Transcriptase (Promega, Madison, USA). For detection of miRNAs,
2 lg of total RNA, miRNA-speciﬁc stem-loop RT primers, and
MMLV reverse transcriptase (Promega) were used in reverse tran-
scription following the manufacturer’s protocol. qRT-PCR was per-
formed using an ABI 7300 real-time PCR detection system (Applied
Biosystems by Life Technologies, Grand Island, NY, USA). Fold
changes in expression of each gene were calculated by a compara-
tive threshold cycle (Ct) method using the formula 2(DDCt).2.4. Western blots
Cell lysates were separated by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis and transferred to
polyvinylidene ﬂuoride membranes (PVDF, Millipore, Billerica,
USA); the immune complexes were detected by enhanced chemilu-
minescence (Cell Signaling Technology, Beverly, MA, USA).
Antibodies used were those for total SMAD2, phospho-SMAD2
(Ser 465/467), SMAD4, DNA methyltransferases 1 (DNMT1, Cell
Signaling Technology) and glyceraldehyde phosphate dehydroge-
nase (GAPDH, Sigma).
2.5. Analysis of side population (SP) cells
After treated MHCC97H cells were removed from the culture
dish, washed, resuspended in DMEM/F-12 medium (Gibco) con-
taining 5% FBS, and incubated in a 1.5 ml eppendorf tube at 37 C
for 10 m, they were labeled with 5 mg/ml Hoechst 33342 dye
(Sigma) in the presence or absence of 50 mM verapamil (an inhibi-
tor of ATP-binding cassette transporters, Sigma) at 37 C for 90 m,
followed by counterstaining with 1 mg/ml of propidium iodide
(Sigma) to label dead cells. Then, 1  105 cells were passed through
a FACSVantage ﬂuorescence-activated cell sorter (Becton
Dickinson, East Rutherford, USA).
2.6. Mammosphere assays
In non-adherent 24 well dishes (Costar, US), treated
MDA-MB-231 cells (2  103) were suspended in deﬁned,
serum-free medium composed of DMEM-F12 (Gibco), 10 ng/ml of
human recombinant basic ﬁbroblast growth factor (bFGF, R&D
Systems, Minneapolis, USA), and 10 ng/ml of epidermal growth
factor (EGF, R&D Systems). Cells were grown for 10 days and fed
every 48 h. Mammospheres were then counted under a microscope
(Olympus, Tokyo, Japan).
2.7. Cell transfection and luciferase reporter assay
Con-mimic and miR-148a-mimic were synthesized by RiBoBio.
The pGL3-SMAD2-30UTR (wild type, WT)-Luc construct and
pGL3-SMAD2-30UTR (mutant, MT, lacking the miR-148 binding
sites)-Luc construct were synthesized by Shuntian Biology
(Shanghai, China). The plasmid phRL-tk (used as an internal control
for transfection efﬁciency and cytotoxicity of test chemicals) con-
taining the Renilla luciferase gene was purchased from Promega.
Brieﬂy, cells were plated in 24-well culture dishes. When cells
Table 2
Primers used for qMSP.
Genes Primers (50–30)
miR-148a Methylated
TCGTCGGTAGTTAATAAGAGCG (F)
ACGCCGCCCGCATGCTCCCCAAT (R)
Unmethylated
TTGTTTGTTGGTAGTTAATAAGAGTG (F)
AAACACCACCCACATACTCCCCAAT (R)
miR-155 Methylated
TCGTTTAGGTCGGAGCGTAGCG (F)
AATCGAAAATTTAAAACCG (R)
Unmethylated
TTGTTGTTTAGGTTGGAGTGTAGTG (F)
AAAATCAAAAATTTAAAACCA (R)
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con-mimics or miR-148a-mimics was co-transfected with the
respective reporter construct, by using Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s protocol. The cells
were lysed with passive lysis buffer (Promega), and the lysates
were analyzed immediately with a 96-well plate luminometer
(Berthold Detection System, Pforzheim, Germany). The amounts
of luciferase and Renilla luciferase were measured with the
Dual-Luciferase Reporter Assay System Kit (Promega) following
the manufacturer’s instructions.
2.8. DNA methylation analysis
Cellular DNA was isolated using DNA puriﬁcation kits (Qiagen,
Germantown, MD, USA). The genomic DNA was modiﬁed with
sodium bisulﬁte using the EpiTect Kit (Qiagen). DNA methylation
was analyzed using a SYBR Green-based quantitative
methylation-speciﬁc PCR (qMSP) as described previously [17].
Primers used were listed in Table 2. Brieﬂy, 1 ll of
bisulﬁte-treated DNA template was mixed with 10 ll of
2  Power SYBR Green PCR Master Mix (Applied Biosystems) and
a pair of primers in a ﬁnal concentration of 400 nM. The PCR con-
ditions included initial incubation at 50 C for 2 min, denaturing at
95 C for 10 min, and 40 cycles of denaturing at 95 C for 15 s and
annealing at 60 C for 1 min.
2.9. Statistical analysis
Data were presented as the means ± SD. A Student’s t test, and a
one-way analysis of variance (ANOVA) followed by Dunnett’s t test
were used to assess signiﬁcant differences between groups. P val-
ues <0.05 were considered statistically signiﬁcant.3. Results
3.1. CaA decreases the CSCs-like properties of human cancer cells
An increased exhibition of CSCs-like properties plays a key role
in the initiation, development, and outcome of various human can-
cers [1]. CD44 and EpCAM are the cell-surface markers of HCC stem
cells [18], while CD44 and ALDH-1 are the cell-surface markers of
BC stem cells [5]. Here, CaA did not appreciably affect the viability
of these cells at the concentration of 20 lM (Fig. S1A), but signiﬁ-
cantly decreased the expressions of CD44, EpCAM, and/or ALDH-1
(Fig. 1A and B). Oct-4, BMI-1, and Lin-28B are the key ‘stemness’
CSCs-associated genes in various cancers including HCC and
TNBC [19–21]. Here, after exposure of these two cells to CaA, the
expression of these mRNAs was signiﬁcantly decreased
(Fig. 1A and B). SP cells are enriched along with stem cells [5].
We then used ﬂow cytometric analysis and found that the percent-
age of SP cells was decreased in the CaA-treated MHCC97H cells
(Fig. 1C and D). Formation of mammospheroids demonstrates the
capacity of cells for self-renewal and for the initiation/develop-
ment of tumors, which are characteristics of bSCs and bCSCs [5].
As shown in Fig. 1E and F, CaA decreased the formation of mammo-
spheroids effectively. Collectively, these results indicate that CaA
attenuates the CSCs-like properties in MHCC97H and
MDA-MB-231 cells.
3.2. CaA inhibits the TGFb-SMADs signal pathway
TGFb-SMADs signal pathway has been shown to increase the
stem-like properties in human cancer cells, including HCC and
TNBC [5,15]. We ﬁrst examined the effects of CaA on the activation
of SMAD2 and SMAD4 in TGFb-treated MDA-MB-231 cells. Asshown in Fig. 2A, CaA blocked the TGFb-induced phosphorylation
of SMAD2 in a dose-dependent manner. Interestingly, CaA attenu-
ated the expression of total SMAD2 and SMAD4. So we next deter-
mined the effects of CaA on the expressions/activation of
endogenous SMAD2 and SMAD4. As shown in Fig. 2B, with
increased time of CaA exposure, there were greater decreased
expressions of pSMAD2, total SMAD2, and SMAD4. Further, we
examined the effects of CaA on the transcriptional activities of
SMAD2 and its downstream factors (snail and CDH-1). As shown
in Fig. 2C and D, there were decreased expressions of SMAD2 and
snail, but increased expression of CDH-1 in CaA-treated cells.
These results indicate that CaA inhibits the TGFb-SMADs signaling
pathway in MHCC97H and MDA-MB-231 cells. Further, the repres-
sive effects of CaA on SMAD2 activity may not via the classical
kinase signaling, because CaA decreased the expression of total
SMAD2. MiRNAs are key regulators of gene expression, degrading
mRNA or repressing translation in a post-transcriptional manner.
Based on our current results, we hypothesized that miRNA
might play a role in the CaA-induced attenuation of endogenous
SMAD2.
3.3. MiR-148a is involved in the CaA-induced attenuation of SMAD2
We previously found that the expression of SMAD2 was
repressed by miR-148a and miR-155 [15,22]. Meanwhile, it is pre-
dicted that SMAD2 might be regulated by other miRNAs, such as
miR-206. So, we examined those potential miRNAs in
CaA-treated MHCC97H cells. As shown in Fig. 3A, CaA elevated
the expressions of these three miRNAs in MHCC97H cells.
Interestingly, overexpression of miR-148a (Fig. 3B) elevated the
expressions of miR-155 and miR-206 in MHCC97H and
MDA-MB-231 cells (Fig. 3C). In addition, knockdown of miR-148a
(Fig. 3D) partly attenuated the CaA-induced elevation of miR-155
and miR-206 in MHCC97H cells (Fig. 3E). So we chose miR-148a
for further investigation.
We then used luciferase reporter analysis to examine if SMAD2
was a direct target gene of miR-148a. The target sites and the wild
type (WT)/or mutated (MT) SMAD2-30UTR-Luc construct were
exhibited in Fig. S2. Interestingly, co-transfected with
pGL3-SMAD2-30UTR-Luc construct (WT, but not MT) plus
miR-148a-mimic led to a signiﬁcant decrease of the luciferase
activity in MHCC97H cells (Fig. 4A). Then we determined the
effects of miR-148a on the expression of SMAD2. As shown in
Fig. 4B–D, knockdown of miR-148a blocked the CaA-induced
decreased expression of SMAD2. Further, overexpression of
miR-148a by itself without CaA treatment decreased the
SMAD2 level (Fig. 4E and F). These results suggest that CaA
inhibits the SMAD2 by miR-148a in MHCC97H and MDA-MB-231
cells.
Fig. 1. CaA decreases the CSCs-like properties of human cancer cells. MHCC97H and MDA-MB-231 cells were treated by 0 or 20 lM CaA for 72 h. (A) qRT-PCR analyses of
CD44, EpCAM, BMI-1, Oct-4, and Lin-28B in MHCC97H cells (mean ± SD, n = 3). (B) qRT-PCR analyses of CD44, ALDH-1, BMI-1, Oct-4, and Lin-28B in MDA-MB-231 cells
(mean ± SD, n = 3). (C and D) FACS analyses of the percentage of SP cells in MHCC97H cells (mean ± SD, n = 3). (E) Mammospheres formed by MDA-MB-231 cells
(bar = 250 lm). (F) Mammospheres quantitation (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with medium control cells.
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Studies indicate that there are many CpG-rich regions in
miR-148a promoter, and that the silencing of miR-148a by DNA
hypermethylation is an early event in human carcinogenesis
[23,24]. Since biotransformation of CaA results in a deﬁciency of
methyl donors, reducing DNA methylation (illustrated in Fig. 5),
and since the catechol-O-methyltransferase (COMT), which isinvolved in the biotransformation of CaA, is rich in human HCC
and BC cells [11,25], we hypothesized that CaA up-regulated the
expression of miR-148a by demethylation.
To conﬁrm this hypothesis, qMSP was conducted. As shown in
Fig. 6A and B, the average methylation level of miR-148a
promoter was high in medium control MHCC97H cells, but low
in CaA-treated MHCC97H cells. Then, we determined the effects
of CaA on the methylation status for miR-155 [a SMAD2
Fig. 2. CaA inhibits the TGFb-SMADs signal pathway. (A) After MDA-MB-231cells were pretreated by 0, 10, or 20 lM CaA for 48 h, they were exposed to 0 or 10 ng/ml TGFb
for 24 h. Western blot analyses of the expressions of SMAD2, p-SMAD2, and SMAD4. (B) MHCC97H and MDA-MB-231 cells were treated by 0 or 20 lM CaA for 24 or 48 h,
respectively. Western blot analyses of the expressions of SMAD2, p-SMAD2, and SMAD4. (C) MHCC97H and MDA-MB-231 cells were treated by 0 or 20 lM CaA for 48 h,
respectively. qRT-PCR analyses of SMAD2 (mean ± SD, n = 3). (D) MHCC97H cells were treated by 0 or 20 lM CaA for 48 h. qRT-PCR analyses of Snail and CDH-1 (mean ± SD,
n = 3). ⁄⁄p < 0.01 compared with medium control cells.
Fig. 3. CaA enhances the expression of miR-148a, miR-155, and miR-206. MHCC97H cells were treated by 0 or 20 lM CaA for 48 h, respectively. (A) qRT-PCR analyses of miR-
206, miR-155, and miR-148a (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with medium control cells. (B and C) MHCC97H or MDA-MB-231 cells were transfected by con-mimic or
miR-148a-mimic for 12 h, respectively. qRT-PCR analyses of miR-148a, miR-155 and miR-206 (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with cells transfected by con-mimic. (D
and E) After MHCC97H cells were transfected by anti-con or anti-miR-148a for 12 h, they were treated with 0 or 20 lM CaA for 48 h, respectively. qRT-PCR analyses of miR-
148a, miR-155 and miR-206 (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with medium control cells. #p < 0.05 and ##p < 0.01 compared with cells treated by 20 lM CaA alone or
with anti-con-transfected cells treated by 20 lM CaA.
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cers [26]]. As shown in Fig. S3A and B, CaA also decreased the
average methylation level in miR-155 promoter. We then tested
the functional relevance of CaA-induced DNA demethylation andincreased expression of miR-148a and miR-155. As shown in
Fig. 6C and S3C, hypermethylation treatment by SAM dramati-
cally blocked the CaA-induced elevation of miR-148a and
miR-155.
Fig. 4. CaA decreased the expression of SMAD2 by miR-148a. (A) MHCC97H and MDA-MB-231 cells were co-transfected with pGL3-SMAD2-30UTR (WT or MT)-Luc construct
plus con-mimc or with pGL3-SMAD2-30UTR (WT or MT)-Luc construct plus miR-148a-mimic for 12 h. Luciferase reporter assays of the effects of miR-148a on SMAD2-30UTR.
(B-D) After MHCC97H or MDA-MB-231 cells were transfected by anti-con or anti-miR-148a for 12 h, they were treated with 0 or 20 lM CaA for 48 h, respectively. qRT-PCR
and/or Western blot analyses of miR-148a and SMAD2 (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with medium control cells; ##p < 0.01 compared with cells treated by 20 lM
CaA alone or with anti-con-transfected cells treated by 20 lM CaA. (E and F) MDA-MB-231 cells were transfected by con-mimic or miR-148a-mimic for 12 h, respectively. (E)
qRT-PCR analyses of the expressions of miR-148a and SMAD2 (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with cells transfected by con-mimic. (F) Western blots analyses of the
expression of SMAD2.
Fig. 5. A pathway showing the demethylation effects induced by CaA. Schematic
illustration of the enzymatic DNA methylation and its modulation by the COMT-
mediated metabolic O-methylation of CaA. During the COMT-mediated metabolic
O-methylation of CaA, there was a deﬁciency of methyl donors (SAM), however, the
formation of SAH would be markedly increased. It is hypothesized that elevated
intracellular levels of SAH due to metabolic O-methylation of CaA may exert a
strong feedback inhibition of DNMT-mediated DNA methylation.
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DNMT1, which down-regulates the expression of DNMT1 in breast
cancer cells [23]. Here in our present study, overexpression of
miR-148a (Fig. 7A) decreased the expression of DNMT1 (Fig. 7B);
moreover, CaA decreased the expression of DNMT1 in
MDA-MB-231 cells (Fig. 7C); further, knockdown of miR-148a
(Fig. 7D) blocked this phenomenon (Fig. 7E). These results suggest
that CaA up-regulates the expression of miR-148a by demethyla-
tion in MHCC97H and MDA-MB-231 cells.
3.5. CaA decreases the CSCs-like properties of by miR-148a
Since the activation of TGFb-SMADs signal enhances the
CSCs-like properties [15], and since miR-148a targeted SMAD2,we hypothesized that CaA attenuated the CSCs-like properties by
miR-148a. Here, knockdown of miR-148a blocked the
CaA-induced decreased expressions of CD44, EpCAM, and ALDH-1
(Fig. 8A and B). Moreover, knockdown of miR-148a blocked the
CaA-induced inhibition of the percentage of SP cells in MHCC97H
cells (Fig. 8C and D). Further, knockdown of miR-148a blocked
the CaA-induced decreased formation of mammospheroids in
MDA-MB-231 cells (Fig. 8E and F). These results indicate that
CaA decreases the CSCs-like properties of by miR-148a in
MHCC97H and MDA-MB-231 cells.
3.6. Effects of CaA on miR-148a/SMAD2 and CSCs-like properties
in vivo
Finally, we investigated the effects of CaA on miR-148a/SMAD2
signaling and on the CSCs-like properties in vivo. Firstly, we con-
ducted a mice xenograft model, 5  106 MHCC97H cells were
injected subcutaneously into the right armpit of the mice. After
the establishment of the tumors, CaA (0 or 10 mg/kgBW) was
administered intraperitoneally twice per week for 11 weeks. As
shown in Fig. 9A, CaA decreased the tumor growth. However, the
body weight and liver weight were similar in both vehicle and
CaA-treated mice (Table. 3). Then we further determined the
effects of CaA on miR-148a, SMAD2, and CSCs-like properties. For
each group, total RNA isolated from tumors (n = 6) were mixed,
and qRT-PCR were performed. As shown in Figs. 9B–G, in
CaA-treated group, there were decreased expressions of CD44,
EpCAM, Oct-4, Lin-28B, and SMAD2, but increased expression of
miR-148a. These results indicate that CaA improves the expression
of miR-148a but inhibits the expression of SMAD2 and CSCs-like
properties in vivo.
4. Discussion
Hydroxycinnamic acid derivatives are reported to have anti-
cancer, anti-inﬂammatory, and antioxidant properties. Their natu-
ral origin and ubiquitous occurrence have prompted strong
interest in their use as anticancer agents [27]. CaA is the major
Fig. 6. CaA up-regulates the expression of miR-148a by demethylation. MHCC97H cells were treated by 0 or 20 lM CaA for 48 h. (A) qMSP analyses and (B) average
methylation level of miR-148a promoter. (C) MHCC97H or MDA-MB-231 cells were treated by 0 or 20 lM CaA in the presence or absence of 100 lM SAM for 48 h,
respectively. qRT-PCR analyses of miR-148a (mean ± SD, n = 3). ⁄⁄p < 0.01 compared with medium control cells, ##p < 0.01 compared with cells treated by 20 lM CaA alone.
Fig. 7. Relationships between CaA, miR-148a, and DNMT1. (A and B) MDA-MB-231 cells were transfected by con-mimic or miR-148a-mimic for 12 h, respectively. qRT-PCR
and/or Western blot analyses of the expression of miR-148a and DNMT1. (C) MDA-MB-231 cells were treated by 0 or 20 lM CaA for 24 or 48 h, respectively. qRT-PCR (top)
andWestern blot (bottom) analyses of the expression of DNMT1. (D and E) After MDA-MB-231 cells were transfected by anti-con or anti-miR-148a for 12 h, they were treated
with 0 or 20 lM CaA for 48 h, respectively. qRT-PCR and/or Western blot analyses of the expression of miR-148a and DNMT1. ⁄p < 0.05 and ⁄⁄p < 0.01 compared with medium
control cells, ##p < 0.01 compared with cells treated by 20 lM CaA plus anti-con, DDp < 0.01 compared with cells transfected by con-mimic.
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have indicated that the daily intake of coffee was associated with
a reduced incidence of colon and rectal cancer. Michels et al.
reported that participants who regularly consumed two or more
cups of decaffeinated coffee per day had a 52% lower incidence of
rectal cancer than those who never consumed decaffeinated coffee
[28]. A similar conclusion has also been reported by Tavani et al.,
who found that, compared with coffee non-drinkers, the risk of
colon cancer was reduced in drinkers of 4 or more cups/day [29].
In the human diet, daily intake of CaA in coffee drinkers is about
0.5–1 g (approximately 0.5–1 mM), and the absorption ratio of
CaA is about 95%. However, part of CaA from foods will enter into
the blood circulation, but most will reach the colon [30], so we
used a relative lower concentration of CaA (20 lM) to investigate
the functions of CaA on the progression of cancers. Here, CaA did
not appreciably affect the viability of MHCC97H andMDA-MB-231 cells (Fig. S1A), moreover, there was also no detect-
able cytotoxicity of CaA on L-02 (human liver epithelial cell line)
and MCF-10A (human breast epithelial cell line) cells (Fig. S1B).
However, CaA attenuates the CSCs-like properties in MHCC97H
and MDA-MB-231 cells, which may be associated with the inhibi-
tion of TGFb/SMAD2 signaling.
In general, the TGFb signaling is initiated with ligand-induced
oligomerization of serine/threonine receptor kinases and phospho-
rylation of the cytoplasmic signaling molecules, Smad2 and Smad3
[31]. Although the switch of TGFb from a tumor suppressor to a
tumor promoter is not well deﬁned, there is evidence that TGFb
plays an important role as an activator of tumor growth andmetas-
tasis. In the liver, TGFb is the most potent hepatic pro-ﬁbrogenic
cytokine predominantly produced by activated mesenchymal cells
upon chronic liver damage [32,33]. Further, TGFb is an important
link between chronic injury, cirrhosis, and HCC, and may serve as
Fig. 8. CaA decreases the CSCs-like properties of by miR-148a. After MHCC97H or MDA-MB-231 cells were transfected by anti-con or anti-miR-148a for 12 h, they were
treated with 0 or 20 lM CaA for 72 h, respectively. (A) qRT-PCR analyses of CD44 and EpCAM in MHCC97H cells (mean ± SD, n = 3). (B) qRT-PCR analyses of CD44 and ALDH-1
in MDA-MB-231 cells (mean ± SD, n = 3). (C and D) FACS analyses of the percentage of SP cells in MHCC97H cells (mean ± SD, n = 3). (E) Free-ﬂoating, viable mammospheres
formed by MDA-MB-231 cells (bar = 250 lm). (F) Mammospheres quantitation (mean ± SD, n = 3); ⁄p < 0.05 and ⁄⁄p < 0.01 compared with medium control cells, and
##p < 0.01 compared with anti-con-transfected cells treated by 20 lM CaA.
Fig. 9. Effects of CaA on miR-148a/SMAD2 and CSCs-like properties in vivo. After MHCC97H cells were injected subcutaneously into the right armpit of the mice for 3 weeks,
CaA (0 or 10 mg/kgBW) was administered (i.p) twice per week. After 11 weeks, the mice were sacriﬁced, and the tumor tissues were removed for further investigation. (A)
Tumor volumes were measured weekly and tumor size was calculated using the formula: V = ½ (width2  length); (B–G) Total RNA isolated from tumors (n = 6) were mixed,
qRT-PCR analyses of the expression of (B) CD44, (C) EpCAM, (D) Oct-4, (E) Lin-28B, (F) SMAD2, and (G) miR-148a (mean ± SD, n = 3). ⁄⁄p < 0.01 compared tumors treated with
no CaA.
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Table 3
Liver weight and body weight in nude mice treated with vehicle (0.1% DMSO) or CaA
(10 mg/kgBW).
Treatment Liver weight Body weight
Vehicle (0.1% DMSO) 2.62 ± 0.19 27.79 ± 3.55
CaA (10 mg/kgBW) 2.37 ± 0.27 30.22 ± 1.61
474 Y. Li et al. / FEBS Open Bio 5 (2015) 466–475a key target for HCC therapy [32,33]. In BC, activation of TGFb attri-
butes to the initiation of EMT, which increases tumor cell invasion.
Meanwhile, the EMT process induced by TGFb generates cells with
a stable bCSCs phenotype, which is demonstrated by increased
self-renewing and tumorigenicity [34,35]. Currently, TGFb inhibi-
tors have been proposed and are being developed as
anti-metastatic agents [33,36]. One proposal is that inhibition of
TGFb blocks the generation of CSCs, which enhances the
chemotherapy action against TNBC [5]. In our present study, CaA
decreased the TGFb-induced phosphorylation of SMAD2.
Importantly, CaA also attenuated the expression of total SMAD2.
Based on these results, we hypothesized that the repressive effects
of CaA on the endogenous SMAD2 may be via miRNAs, resulting in
the degradation of mRNAs.
MiRNAs are small non-coding RNAs that regulate gene expres-
sion by binding to the 30-UTR of the target mRNA and inhibiting
translation or targeting the mRNA for degradation [37].
Currently, the miRNAs networks and their regulation of mRNA
translation and protein expression in the CSCs-like properties
remain to be elucidated. Here, we picked out three SMAD2 associ-
ated miRNAs, miR-148a, miR-155, and miR-206. Interestingly,
miR-148a elevated the expressions of miR-155 and miR-206.
There are two possible reasons for this. First, miR-155 is reported
to be epigenetically silenced in human cancers [26]. Meanwhile,
miR-148a has been identiﬁed as a DNMT1 target miRNA in breast
cancer cells [23]. So the up-regulation of miR-155 by miR-148a
might be via the DNA demethylation; Second, Winbanks et al.
reported that TGFb reduced the endogenous expression of the pri-
mary and mature forms of miR-206 [38]. Since miR-148a targeted
SMAD2, we hypothesized that the up-regulation of miR-206 by
miR-148a might be via the inhibition of TGFb/SMADs pathway.
Based on these results, we chose miR-148a for further
investigation.
MiR-148a was ﬁrst shown to modulate the levels of cytochrome
P450 3A4 via post-transcriptionally regulating the 30UTR of the
Pregnane X Receptor (PXR) mRNA [39]. Meanwhile, miR-148a is
also a pro-apoptotic miRNA that targets Bcl-2 [40]. In addition,
inhibition of miR-148a by hyper-methylation is associated with
metastasis in many tumor types and with up-regulation of
metastasis-associated genes [41]. Further miR-148a is involved in
the anti-metastasis of HCC cells by the inhibitions of
Wnt1-mediated EMT and acquirement of CSCs-like properties
[37]. In breast cancer MCF-7 cells, miR-148a inhibits angiogenesis
by targeting erythroblastic leukemia viral oncogene homolog 3
(ERBB3), which blocks the downstream pathway activation includ-
ing protein kinase B (PKB), extracellular signal regulated kinases
(ERKs), and hypoxia-inducible factor 1 alpha (HIF-1a) [42]. We
previously found that, miR-148a down-regulated SMAD2 in
glabridin-treated HepG2 cells [15]. Here, by use of luciferase repor-
ter assay, qRT-PCR, and western blot, we conﬁrmed the direct rela-
tionship between miR-148a and SMAD2 in CaA-treated MHCC97H
cells. Further, we found that the up-regulation of miR-148a by CaA
might via the DNA demethylation in miR-148a promoter.
Methylation of CaA requires SAM as a cofactor, which causes
the demethylation of DNA [11]. A previous study indicates that
there are many CpG-rich regions in miR-148a promoter [23]. So
we hypothesized that CaA up-regulated the expression of
miR-148a by demethylation. Our data showed that the averagemethylation level of miR-148a promoter in CaA-treated
MHCC97H cells was lower than that in medium control cells.
Further, hypermethylation treatment by SAM dramatically blocked
the CaA-induced elevation of miR-148a. Moreover, as shown in
Fig. S3A–C, CaA also decreased the average methylation level in
miR-155 promoter. DNMTs are responsible for DNA methylation
[11]. Interestingly, miR-148a has been identiﬁed to target
DNMT1, which down-regulates the expression of DNMT1 in breast
cancer cells [23]. In our study, overexpression of miR-148a
decreased the expression of DNMT1 (Fig. 7A and B). Further, CaA
decreased the expression of DNMT1 in MDA-MB-231 cells, how-
ever, knockdown of miR-148a blocked this phenomenon
(Fig. 7D and E). So we further hypothesized that there might be a
feedback loop between miR-148a and DNMT1 in CaA-treated
human cancer cells, that was reduced DNMT1 would further
reduce the demethylation on miR-148a promoter.
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